FDA ERRATA To FDA Advisory Committee Briefing Documents PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE MEETING March 8, 2011 NDA[removed]Indacaterol maleate (Arcapta Neohaler) for the long-term, once-daily, maintenance treatm - Acute exacerbations of chronic bronchitis - Document - PDFSEARCH.IO

First Page	Meta Content
	FDA ERRATA To FDA Advisory Committee Briefing Documents PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE MEETING March 8, 2011 NDA[removed]Indacaterol maleate (Arcapta Neohaler) for the long-term, once-daily, maintenance treatm Add to Reading List Open Document File Size: 11,25 KB Share Result on Facebook MedicalCondition COPD / chronic bronchitis / chronic obstructive pulmonary disease / / Organization FDA ERRATA To FDA Advisory Committee Briefing Documents PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE / / SocialTag Pulmonology Respiratory therapy Acute exacerbation of chronic obstructive pulmonary disease Chronic obstructive pulmonary disease Indacaterol Chronic bronchitis Acute exacerbations of chronic bronchitis Tiotropium bromide Chronic lower respiratory diseases Smoking

FDA ERRATA To FDA Advisory Committee Briefing Documents PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE MEETING March 8, 2011 NDA[removed]Indacaterol maleate (Arcapta Neohaler) for the long-term, once-daily, maintenance treatmAdd to Reading List